טוען...
The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
The development of disease modifying strategies in Parkinson’s disease (PD) largely depends on the ability to identify suitable populations after accurate diagnostic work-up. Therefore, patient molecular profiling and disease subtyping are mandatory. Thus far, in clinical trials, PD has been conside...
שמור ב:
| הוצא לאור ב: | Biomolecules |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072459/ https://ncbi.nlm.nih.gov/pubmed/32092971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10020335 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|